237 related articles for article (PubMed ID: 27076766)
21. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
[TBL] [Abstract][Full Text] [Related]
22. Surgical strategy for gastric cancer patients with liver cirrhosis: a retrospective cohort study.
Guo F; Ma S; Yang S; Dong Y; Luo F; Wang Z
Int J Surg; 2014; 12(8):810-4. PubMed ID: 25008280
[TBL] [Abstract][Full Text] [Related]
23. [Advantage of perisplenic hilar lymph node dissection by laparoscopy-assisted total gastrectomy (D2) over conventional open total gastrectomy for advanced gastric cancer].
Zang WD; Zhang H; Chen LC; Zhuo CH; Ying MG
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):864-7. PubMed ID: 22335955
[TBL] [Abstract][Full Text] [Related]
24. Surgical choice of proximal gastric cancer in China: a retrospective study of a 30-year experience from a single center in China.
Zhu Z; Wu P; Du N; Li K; Huang B; Wang Z; Xu H
Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1123-1128. PubMed ID: 31687853
[No Abstract] [Full Text] [Related]
25. Analysis of the short- and long-term outcomes of membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for treating advanced proximal gastric cancer.
Xu Y; Li Z; Pan G; Wu H; Lin W; Chen J; Li J
World J Surg Oncol; 2019 Apr; 17(1):64. PubMed ID: 30967144
[TBL] [Abstract][Full Text] [Related]
26. Open versus laparoscopy-assisted D2 radical gastrectomy in advanced upper gastric cancer: a retrospective cohort study.
Cai J; Zhang C; Zhang H; Zhao T; Lv B; Gao C; Wei D
Hepatogastroenterology; 2013 Oct; 60(127):1805-8. PubMed ID: 24624451
[TBL] [Abstract][Full Text] [Related]
27. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
28. The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy.
Yang K; Chen HN; Liu K; Zhang WH; Chen XZ; Chen XL; Zhou ZG; Hu JK
Oncotarget; 2016 Apr; 7(14):18750-62. PubMed ID: 26959745
[TBL] [Abstract][Full Text] [Related]
29. Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.
Caruso S; Patriti A; Marrelli D; Ceccarelli G; Ceribelli C; Roviello F; Casciola L
Int J Med Robot; 2011 Dec; 7(4):452-8. PubMed ID: 21984205
[TBL] [Abstract][Full Text] [Related]
30. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.
Liu YY; Fang WL; Wang F; Hsu JT; Tsai CY; Liu KH; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
Oncologist; 2017 Jan; 22(1):97-106. PubMed ID: 27789777
[TBL] [Abstract][Full Text] [Related]
31. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
33. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
34. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.
Li Z; Bai B; Zhao Y; Yu D; Lian B; Liu Y; Zhao Q
Int J Surg; 2018 Jun; 54(Pt A):62-69. PubMed ID: 29698790
[TBL] [Abstract][Full Text] [Related]
35. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of No.12 lymph node dissection for advanced gastric cancer].
You X; Wang Y; Li W; Zhao X; Cheng Z; Xu N; Huang C; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):283-288. PubMed ID: 28338161
[TBL] [Abstract][Full Text] [Related]
37. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
[TBL] [Abstract][Full Text] [Related]
39. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
40. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?
Tokunaga M; Ohyama S; Hiki N; Fukunaga T; Aikou S; Yamaguchi T
Ann Surg Oncol; 2010 Aug; 17(8):2031-6. PubMed ID: 20182811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
